News

Value in Health, the official journal of ISPOR, announced the publication of an analysis showing that while value assessment frameworks are moving closer to meeting the challenge of accurately measuring value and reliably informing healthcare decisions, more progress is needed before widespread adoption and use.

Value in Health, the official journal of ISPOR, announced the publication of research demonstrating that discrete choice experiments are able to predict real-world healthcare choices.

ISPOR announced its plenary session and speakers for ISPOR Europe 2019. The conference will be held 2-6 November 2019 in Copenhagen, Denmark.

ISPOR released the final program and speakers for its upcoming ISPOR Latin America 2019 conference that will be held 12-14 September 2019 in Bogotá, Colombia.

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that while expenditures for prescribed medicines have risen significantly in the United States for the past 2 decades, expanded prescription drug coverage has resulted in a significant reduction in patient out-of-pocket drug costs.

Value in Health, the official journal of ISPOR, announced today the publication of a report introducing a new framework by which concerns for affordability can be appropriately incorporated within cost-effectiveness analysis.

ISPOR announced plans for its ISPOR Summit 2019 scheduled for October 11, 2019 in Baltimore, MD, USA.

ISPOR—the professional society for health economics and outcomes research (HEOR)—announced plenary sessions and speakers for its ISPOR Latin America 2019 conference. The leading HEOR conference in Latin America will focus on “Data and Value in Healthcare: 2020 and Beyond” on 12-14 September 2019 in Bogotá, Colombia.

ISPOR—the professional society for health economics and outcomes research announced that it has been awarded multiple dotCOMM awards recognizing its new branding, annual report, and website redesign.

ISPOR, the professional society for health economics and outcomes research, announced that its CEO and Executive Director Nancy S. Berg has been named a 2019 PharmaVOICE Red Jacket Award honoree.